[HTML][HTML] Psychotropics and the microbiome: a chamber of secrets…

S Cussotto, G Clarke, TG Dinan, JF Cryan - Psychopharmacology, 2019 - Springer
The human gut contains trillions of symbiotic bacteria that play a key role in programming
different aspects of host physiology in health and disease. Psychotropic medications act on …

A comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise

KC Howard, EK Dennis, DS Watt… - Chemical Society …, 2020 - pubs.rsc.org
The emergence of new fungal pathogens makes the development of new antifungal drugs a
medical imperative that in recent years motivates the talents of numerous investigators …

Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial

J Rhein, KH Hullsiek, L Tugume… - The Lancet infectious …, 2019 - thelancet.com
Background Identifying new antifungals for cryptococcal meningitis is a priority given the
inadequacy of current therapy. Sertraline has previously shown in vitro and in vivo activity …

[HTML][HTML] Drug repurposing strategies in the development of potential antifungal agents

Q Zhang, F Liu, M Zeng, Y Mao, Z Song - Applied Microbiology and …, 2021 - Springer
The morbidity and mortality caused by invasive fungal infections are increasing across the
globe due to developments in transplant surgery, the use of immunosuppressive agents …

[HTML][HTML] Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis

JR Kelly, G Clarke, A Harkin, SC Corr, S Galvin… - International Journal of …, 2023 - Elsevier
Moving towards a systems psychiatry paradigm embraces the inherent complex interactions
across all levels from micro to macro and necessitates an integrated approach to treatment …

[HTML][HTML] Drug repurposing in medical mycology: Identification of compounds as potential antifungals to overcome the emergence of multidrug-resistant fungi

L Peyclit, H Yousfi, JM Rolain, F Bittar - Pharmaceuticals, 2021 - mdpi.com
Immunodepression, whether due to HIV infection or organ transplantation, has increased
human vulnerability to fungal infections. These conditions have created an optimal …

Cryptococcosis today: it is not all about HIV infection

JA O'Halloran, WG Powderly, A Spec - Current Clinical Microbiology …, 2017 - Springer
Abstract Purpose of the Review Cryptococcal disease is most often thought of in the context
of HIV infection. Much of our knowledge of the disease originates from its management in …

[HTML][HTML] The Antidepressant Sertraline Induces the Formation of Supersized Lipid Droplets in the Human Pathogen Cryptococcus neoformans

MR Breuer, A Dasgupta, JG Vasselli, X Lin, BD Shaw… - Journal of Fungi, 2022 - mdpi.com
The prevalence and increasing incidence of fungal infections globally is a significant
worldwide health problem. Cryptococcosis, primarily caused by the pathogenic yeast …

The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans

TP Hai, AD Van, NTT Ngan, LTH Nhat, NPH Lan… - Mycoses, 2019 - Wiley Online Library
Background Cryptococcal meningitis has fatality rates of 40%‐70%, resulting in 200 000
deaths each year. The best outcomes are achieved with amphotericin combined with …

Antifungal activity of selective serotonin reuptake inhibitors against Cryptococcus spp. and their possible mechanism of action

CR da Silva, LGAV Sá, TL Ferreira, AC Leitão… - Journal of Medical …, 2023 - Elsevier
Fungal infections caused by Cryptococcus spp. pose a threat to health, especially in
immunocompromised individuals. The available arsenal of drugs against cryptococcosis is …